Atai Life Sciences PE Ratio 2020-2024 | ATAI

Current and historical p/e ratio for Atai Life Sciences (ATAI) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Atai Life Sciences PE ratio as of July 22, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Atai Life Sciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-07-22 1.49 0.00
2024-03-31 1.97 $-0.25 0.00
2023-12-31 1.41 $-0.29 0.00
2023-09-30 1.29 $-0.45 0.00
2023-06-30 1.72 $-0.92 0.00
2023-03-31 1.81 $-0.95 0.00
2022-12-31 2.66 $-0.98 0.00
2022-09-30 3.31 $-1.33 0.00
2022-06-30 3.64 $-1.32 0.00
2022-03-31 5.09 $-1.45 0.00
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.249B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00